A non-medical overview of how Sprout Health NAD⁺ Injections supports energy, cellular function, and wellness in a remote telehealth setting.
Read More
UPDATE - Contact information has been updated on this release as of September 9, 2025
A remote-first, doctor-reviewed telehealth program offering access to personalized care plans and GLP-1 evaluations using semaglutide or tirzepatide.
At-home medical service offers streamlined access to GLP-1 prescriptions like Ozempic®, Semaglutide, and Tirzepatide with no insurance requirements or in-person visits.
Read More
-- David Cory is an industry veteran, bringing more than 30 years of operational experience, in private and public, emerging-stage biotech and large pharma companies with an established track record of building and leading high performing operating teams and financing in the capital markets with over $1B+ raised and multiple company exits by acquisition
-- CID-103 is a potential best in class, anti-CD38 monoclonal antibody, currently dosing in a multi-center Phase 1/2 study in adults with chronic immune thrombocytopenia (ITP); IND submitted to support future clinical trials in adults with renal allograft antibody-mediated rejection (AMR)
Read More
The new series empowers audiences to help revive forgotten cold cases through immersive storytelling, firsthand accounts, and direct access to active investigations in hopes of sparking new leads and finding justice for overlooked victims.
Read MoreCorrection to the number of shares in the first paragraph
Upon Completion of the 10-Q Quarterly Interim Review filing, Cytta Corp will be Current and Will Regain OTCQB Status
Read More
The live podcast event for thousands of fans returns Saturday, September 6th for an unforgettable night of hoops, culture, comedy, and music. Featuring Eli Manning, Ben Stiller, and more notable guests, plus a live musical performance by Ferg.
Tickets On-Sale This Friday 10:00AM ET
Read More